instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS).
We report five patients with lung disease immuno-deficiency and chromosome breakage syndrome (LICS) but without recurrent infections and severe immunodeficiency. One patient had extended survival to 6.5 ye... | DEXAMETHASONE | DrugsGivenReaction | CC BY | 33741030 | 19,164,086 | 2021-03-19 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS).
We report five patients with lung disease immuno-deficiency and chromosome breakage syndrome (LICS) but without recurrent infections and severe immunodeficiency. One patient had extended survival to 6.5 ye... | PULSE THERAPY | DrugDosageText | CC BY | 33741030 | 19,167,260 | 2021-03-19 |
What was the outcome of reaction 'Drug ineffective'? | New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS).
We report five patients with lung disease immuno-deficiency and chromosome breakage syndrome (LICS) but without recurrent infections and severe immunodeficiency. One patient had extended survival to 6.5 ye... | Fatal | ReactionOutcome | CC BY | 33741030 | 19,139,127 | 2021-03-19 |
What was the outcome of reaction 'Pneumomediastinum'? | New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS).
We report five patients with lung disease immuno-deficiency and chromosome breakage syndrome (LICS) but without recurrent infections and severe immunodeficiency. One patient had extended survival to 6.5 ye... | Fatal | ReactionOutcome | CC BY | 33741030 | 19,164,086 | 2021-03-19 |
What was the outcome of reaction 'Pneumothorax'? | New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS).
We report five patients with lung disease immuno-deficiency and chromosome breakage syndrome (LICS) but without recurrent infections and severe immunodeficiency. One patient had extended survival to 6.5 ye... | Fatal | ReactionOutcome | CC BY | 33741030 | 19,164,086 | 2021-03-19 |
What was the outcome of reaction 'Respiratory failure'? | New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS).
We report five patients with lung disease immuno-deficiency and chromosome breakage syndrome (LICS) but without recurrent infections and severe immunodeficiency. One patient had extended survival to 6.5 ye... | Fatal | ReactionOutcome | CC BY | 33741030 | 19,164,086 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood glucose fluctuation'. | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | AMLODIPINE BESYLATE, ATORVASTATIN, CALCITRIOL, CETUXIMAB, DULAGLUTIDE, EMPAGLIFLOZIN, FLUOROURACIL, FUROSEMIDE, INSULIN NOS, IRINOTECAN, LEUCOVORIN, LOSARTAN, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PANITUMUMAB, PANTOPRAZOLE, POTASSIUM, TACROLIMUS | DrugsGivenReaction | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coma'. | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | AMLODIPINE BESYLATE, ATORVASTATIN, CALCITRIOL, DULAGLUTIDE, EMPAGLIFLOZIN, FLUOROURACIL, FUROSEMIDE, INSULIN NOS, IRINOTECAN, LEUCOVORIN, LOSARTAN, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PANITUMUMAB, PANTOPRAZOLE, TACROLIMUS | DrugsGivenReaction | CC BY | 33741057 | 19,062,706 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic stroke'. | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | AMLODIPINE BESYLATE, ATORVASTATIN, CALCITRIOL, DULAGLUTIDE, EMPAGLIFLOZIN, FLUOROURACIL, FUROSEMIDE, INSULIN NOS, IRINOTECAN, LEUCOVORIN, LOSARTAN, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PANITUMUMAB, PANTOPRAZOLE, TACROLIMUS | DrugsGivenReaction | CC BY | 33741057 | 19,062,706 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to lymph nodes'. | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | AMLODIPINE BESYLATE, ATORVASTATIN, CALCITRIOL, DULAGLUTIDE, EMPAGLIFLOZIN, FLUOROURACIL, FUROSEMIDE, INSULIN NOS, IRINOTECAN, LEUCOVORIN, LOSARTAN, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PANITUMUMAB, PANTOPRAZOLE, TACROLIMUS | DrugsGivenReaction | CC BY | 33741057 | 19,062,706 | 2021-03-20 |
What was the dosage of drug 'CETUXIMAB'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | RECEIVED ONE CYCLE WITH FOLINIC?ACID, FLUOROURACIL AND IRINOTECAN | DrugDosageText | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the dosage of drug 'FLUOROURACIL'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | FOLFIRI REGIMEN; RECEIVED WITH ONE CYCLE OF CETUXIMAB AND THREE CYCLE OF PANITUMUMAB | DrugDosageText | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the dosage of drug 'INSULIN NOS'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | RAPID? AND LONG?ACTING INSULIN | DrugDosageText | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the dosage of drug 'IRINOTECAN'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | FOLFIRI REGIMEN; RECEIVED WITH ONE CYCLE OF CETUXIMAB AND THREE CYCLE OF PANITUMUMAB | DrugDosageText | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the dosage of drug 'LEUCOVORIN'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | FOLFIRI REGIMEN; RECEIVED WITH ONE CYCLE OF CETUXIMAB AND THREE CYCLE OF PANITUMUMAB | DrugDosageText | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the outcome of reaction 'Blood glucose fluctuation'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | Recovering | ReactionOutcome | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the outcome of reaction 'Colon cancer metastatic'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | Recovered | ReactionOutcome | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the outcome of reaction 'Diarrhoea'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | Recovering | ReactionOutcome | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the outcome of reaction 'Haemorrhagic stroke'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | Fatal | ReactionOutcome | CC BY | 33741057 | 19,062,706 | 2021-03-20 |
What was the outcome of reaction 'Hypomagnesaemia'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | Recovering | ReactionOutcome | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the outcome of reaction 'Rash'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | Recovering | ReactionOutcome | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
What was the outcome of reaction 'Weight decreased'? | Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.
BACKGROUND
Previous studies have shown that patients who underwent renal transplantation were at a greater risk of developing malignancies. Du... | Recovering | ReactionOutcome | CC BY | 33741057 | 19,168,356 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diplopia'. | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33741573 | 19,281,054 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exophthalmos'. | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33741573 | 19,281,054 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathological fracture'. | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33741573 | 19,197,480 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Plasma cell myeloma'. | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | BORTEZOMIB, CISPLATIN, CYCLOPHOSPHAMIDE, DARATUMUMAB, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, PREDNISOLONE, THALIDOMIDE | DrugsGivenReaction | CC BY-NC | 33741573 | 19,208,321 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33741573 | 19,281,054 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ureterolithiasis'. | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33741573 | 19,197,480 | 2021-03-19 |
What was the dosage of drug 'DARATUMUMAB'? | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | FIRST CYCLE | DrugDosageText | CC BY-NC | 33741573 | 19,208,321 | 2021-03-19 |
What was the dosage of drug 'DEXAMETHASONE'? | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | FIRST CYCLE | DrugDosageText | CC BY-NC | 33741573 | 19,208,321 | 2021-03-19 |
What was the dosage of drug 'DOXORUBICIN'? | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | SEVEN CYCLES OF VCAP | DrugDosageText | CC BY-NC | 33741573 | 19,197,480 | 2021-03-19 |
What was the dosage of drug 'PREDNISOLONE'? | Rare case of plasmablastic myeloma diagnosed on lung biopsy.
Plasmablastic myeloma is a rare variant of multiple myeloma characterised by neoplastic proliferation of single clone of plasma cells producing monoclonal immunoglobulins. A 60-year-old man presented to hospital with a 6-week history of chest pain, back pain,... | SEVEN CYCLES OF VCAP | DrugDosageText | CC BY-NC | 33741573 | 19,197,480 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematotoxicity'. | Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma.
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated heterogeneous disease and is characterized by peritumoral immune infiltrate. Adoptive T-cell therapy (ACT) has emerged as a potential ... | CISPLATIN | DrugsGivenReaction | CC BY | 33742086 | 19,441,793 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma.
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated heterogeneous disease and is characterized by peritumoral immune infiltrate. Adoptive T-cell therapy (ACT) has emerged as a potential ... | CISPLATIN | DrugsGivenReaction | CC BY | 33742086 | 19,441,793 | 2021-03-19 |
What was the dosage of drug 'CISPLATIN'? | Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma.
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated heterogeneous disease and is characterized by peritumoral immune infiltrate. Adoptive T-cell therapy (ACT) has emerged as a potential ... | WEEKS 1 AND 4 AND 7 (HIGH?DOSE ) | DrugDosageText | CC BY | 33742086 | 19,441,793 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | ACETAMINOPHEN, CHLORAL HYDRATE, CHOLECALCIFEROL, ERYTHROMYCIN, MELATONIN, MEROPENEM, MINERALS\PROBIOTICS NOS\VITAMINS, OFLOXACIN, PHENOBARBITAL SODIUM, PHYTONADIONE, PIPERACILLIN SODIUM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PIRITRAMIDE, POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE, R... | DrugsGivenReaction | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'ACETAMINOPHEN'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'CHLORAL HYDRATE'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'CHOLECALCIFEROL'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'MELATONIN'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'MEROPENEM'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'MINERALS\PROBIOTICS NOS\VITAMINS'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'OFLOXACIN'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Topical | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'PHENOBARBITAL SODIUM'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'PIPERACILLIN SODIUM'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'PIRITRAMIDE'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'RANIBIZUMAB'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intraocular | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,153,728 | 2021-03-19 |
What was the administration route of drug 'RANITIDINE HYDROCHLORIDE'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the administration route of drug 'URSODIOL'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
What was the dosage of drug 'OFLOXACIN'? | Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
OBJECTIVE
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE-ROP) ... | UNK (3 DROPS PER DAY) (BOTH EYES) | DrugDosageText | CC BY-NC-ND | 33742551 | 19,154,010 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Occurrence of autoimmune pancreatitis after chronic immune thrombocytopenia in a Caucasian adolescent.
Autoimmune pancreatitis is a rare, distinct and increasingly recognized form of chronic inflammatory pancreatic disease secondary to an underlying autoimmune mechanism. We report on a 14-year-old boy who developed aut... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 33743140 | 19,817,260 | 2021-06 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Occurrence of autoimmune pancreatitis after chronic immune thrombocytopenia in a Caucasian adolescent.
Autoimmune pancreatitis is a rare, distinct and increasingly recognized form of chronic inflammatory pancreatic disease secondary to an underlying autoimmune mechanism. We report on a 14-year-old boy who developed aut... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33743140 | 19,817,260 | 2021-06 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Occurrence of autoimmune pancreatitis after chronic immune thrombocytopenia in a Caucasian adolescent.
Autoimmune pancreatitis is a rare, distinct and increasingly recognized form of chronic inflammatory pancreatic disease secondary to an underlying autoimmune mechanism. We report on a 14-year-old boy who developed aut... | 0.8 GRAM PER KILOGRAM | DrugDosageText | CC BY | 33743140 | 19,817,260 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Central vision loss'. | Presumed Sertraline-Associated Maculopathy: A Case Series.
OBJECTIVE
To report findings of maculopathy after treatment with sertraline in three patients.
METHODS
This case series includes three patients who presented with reduced visual acuity after treatment with sertraline for various psychiatric indications. All p... | SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33743165 | 19,234,039 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Presumed Sertraline-Associated Maculopathy: A Case Series.
OBJECTIVE
To report findings of maculopathy after treatment with sertraline in three patients.
METHODS
This case series includes three patients who presented with reduced visual acuity after treatment with sertraline for various psychiatric indications. All p... | SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33743165 | 19,234,039 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual field defect'. | Presumed Sertraline-Associated Maculopathy: A Case Series.
OBJECTIVE
To report findings of maculopathy after treatment with sertraline in three patients.
METHODS
This case series includes three patients who presented with reduced visual acuity after treatment with sertraline for various psychiatric indications. All p... | PROPRANOLOL HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33743165 | 19,173,487 | 2021-06 |
What was the outcome of reaction 'Central vision loss'? | Presumed Sertraline-Associated Maculopathy: A Case Series.
OBJECTIVE
To report findings of maculopathy after treatment with sertraline in three patients.
METHODS
This case series includes three patients who presented with reduced visual acuity after treatment with sertraline for various psychiatric indications. All p... | Not recovered | ReactionOutcome | CC BY-NC | 33743165 | 19,234,039 | 2021-06 |
What was the outcome of reaction 'Visual field defect'? | Presumed Sertraline-Associated Maculopathy: A Case Series.
OBJECTIVE
To report findings of maculopathy after treatment with sertraline in three patients.
METHODS
This case series includes three patients who presented with reduced visual acuity after treatment with sertraline for various psychiatric indications. All p... | Recovered | ReactionOutcome | CC BY-NC | 33743165 | 19,173,487 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.
OBJECTIVE
Standard piperacillin-tazobactam (P-T) dosing may be suboptimal in obesity, but high-dose regimens have not been studied. We prospectively evaluated the pharmacokinetics and pharmacodynamics of standard- and high-dos... | FUROSEMIDE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 33743171 | 19,436,927 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.
OBJECTIVE
Standard piperacillin-tazobactam (P-T) dosing may be suboptimal in obesity, but high-dose regimens have not been studied. We prospectively evaluated the pharmacokinetics and pharmacodynamics of standard- and high-dos... | LORAZEPAM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY-NC | 33743171 | 19,436,928 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.
OBJECTIVE
Standard piperacillin-tazobactam (P-T) dosing may be suboptimal in obesity, but high-dose regimens have not been studied. We prospectively evaluated the pharmacokinetics and pharmacodynamics of standard- and high-dos... | FUROSEMIDE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 33743171 | 19,436,927 | 2021-05 |
What was the administration route of drug 'LORAZEPAM'? | Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.
OBJECTIVE
Standard piperacillin-tazobactam (P-T) dosing may be suboptimal in obesity, but high-dose regimens have not been studied. We prospectively evaluated the pharmacokinetics and pharmacodynamics of standard- and high-dos... | Oral | DrugAdministrationRoute | CC BY-NC | 33743171 | 19,436,928 | 2021-05 |
What was the outcome of reaction 'Acute kidney injury'? | Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.
OBJECTIVE
Standard piperacillin-tazobactam (P-T) dosing may be suboptimal in obesity, but high-dose regimens have not been studied. We prospectively evaluated the pharmacokinetics and pharmacodynamics of standard- and high-dos... | Recovered | ReactionOutcome | CC BY-NC | 33743171 | 19,436,927 | 2021-05 |
What was the outcome of reaction 'Delirium'? | Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.
OBJECTIVE
Standard piperacillin-tazobactam (P-T) dosing may be suboptimal in obesity, but high-dose regimens have not been studied. We prospectively evaluated the pharmacokinetics and pharmacodynamics of standard- and high-dos... | Recovered | ReactionOutcome | CC BY-NC | 33743171 | 19,436,928 | 2021-05 |
What was the outcome of reaction 'Diarrhoea'? | Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.
OBJECTIVE
Standard piperacillin-tazobactam (P-T) dosing may be suboptimal in obesity, but high-dose regimens have not been studied. We prospectively evaluated the pharmacokinetics and pharmacodynamics of standard- and high-dos... | Recovering | ReactionOutcome | CC BY-NC | 33743171 | 19,436,927 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | A case report of multiple bilateral breast metastases after colorectal cancer.
Although primary breast cancer is the most common tumor in women, breast metastases are rare findings. We report the first case in English literature with CRC metastases to the breast and adrenal gland concurrently.
METHODS
A 42-year-old C... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33743246 | 19,384,764 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A case report of multiple bilateral breast metastases after colorectal cancer.
Although primary breast cancer is the most common tumor in women, breast metastases are rare findings. We report the first case in English literature with CRC metastases to the breast and adrenal gland concurrently.
METHODS
A 42-year-old C... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33743246 | 19,384,764 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | A case report of multiple bilateral breast metastases after colorectal cancer.
Although primary breast cancer is the most common tumor in women, breast metastases are rare findings. We report the first case in English literature with CRC metastases to the breast and adrenal gland concurrently.
METHODS
A 42-year-old C... | FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33743246 | 19,480,765 | 2021-04 |
What was the dosage of drug 'IRINOTECAN HYDROCHLORIDE'? | A case report of multiple bilateral breast metastases after colorectal cancer.
Although primary breast cancer is the most common tumor in women, breast metastases are rare findings. We report the first case in English literature with CRC metastases to the breast and adrenal gland concurrently.
METHODS
A 42-year-old C... | UNK, CYCLIC | DrugDosageText | CC BY | 33743246 | 19,480,765 | 2021-04 |
What was the dosage of drug 'IRINOTECAN'? | A case report of multiple bilateral breast metastases after colorectal cancer.
Although primary breast cancer is the most common tumor in women, breast metastases are rare findings. We report the first case in English literature with CRC metastases to the breast and adrenal gland concurrently.
METHODS
A 42-year-old C... | UNK, 2 CYCLES | DrugDosageText | CC BY | 33743246 | 19,384,764 | 2021-04 |
What was the outcome of reaction 'Disease progression'? | A case report of multiple bilateral breast metastases after colorectal cancer.
Although primary breast cancer is the most common tumor in women, breast metastases are rare findings. We report the first case in English literature with CRC metastases to the breast and adrenal gland concurrently.
METHODS
A 42-year-old C... | Fatal | ReactionOutcome | CC BY | 33743246 | 19,384,764 | 2021-04 |
What was the outcome of reaction 'Neoplasm progression'? | A case report of multiple bilateral breast metastases after colorectal cancer.
Although primary breast cancer is the most common tumor in women, breast metastases are rare findings. We report the first case in English literature with CRC metastases to the breast and adrenal gland concurrently.
METHODS
A 42-year-old C... | Fatal | ReactionOutcome | CC BY | 33743246 | 19,480,765 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Whipple's disease: the great masquerader-a high level of suspicion is the key to diagnosis.
BACKGROUND
Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved. The disease is caused by a gram-positive bacterium called Tropheryma whi... | HYDROXYCHLOROQUINE SULFATE, METHOTREXATE | DrugsGivenReaction | CC BY | 33743602 | 19,900,384 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paradoxical drug reaction'. | Whipple's disease: the great masquerader-a high level of suspicion is the key to diagnosis.
BACKGROUND
Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved. The disease is caused by a gram-positive bacterium called Tropheryma whi... | ABATACEPT, ADALIMUMAB, HYDROXYCHLOROQUINE, INFLIXIMAB, LEVOTHYROXINE, METHOTREXATE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33743602 | 19,977,136 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rheumatoid arthritis'. | Whipple's disease: the great masquerader-a high level of suspicion is the key to diagnosis.
BACKGROUND
Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved. The disease is caused by a gram-positive bacterium called Tropheryma whi... | ABATACEPT, ADALIMUMAB, HYDROXYCHLOROQUINE, INFLIXIMAB, LEVOTHYROXINE, METHOTREXATE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33743602 | 19,977,136 | 2021-03-20 |
What was the dosage of drug 'HYDROXYCHLOROQUINE SULFATE'? | Whipple's disease: the great masquerader-a high level of suspicion is the key to diagnosis.
BACKGROUND
Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved. The disease is caused by a gram-positive bacterium called Tropheryma whi... | 200 mg (milligrams). | DrugDosage | CC BY | 33743602 | 19,900,384 | 2021-03-20 |
What was the dosage of drug 'PREDNISOLONE'? | Whipple's disease: the great masquerader-a high level of suspicion is the key to diagnosis.
BACKGROUND
Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved. The disease is caused by a gram-positive bacterium called Tropheryma whi... | FOR 8 YEARS | DrugDosageText | CC BY | 33743602 | 19,977,136 | 2021-03-20 |
What was the outcome of reaction 'Paradoxical drug reaction'? | Whipple's disease: the great masquerader-a high level of suspicion is the key to diagnosis.
BACKGROUND
Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved. The disease is caused by a gram-positive bacterium called Tropheryma whi... | Recovering | ReactionOutcome | CC BY | 33743602 | 19,977,136 | 2021-03-20 |
What was the outcome of reaction 'Rheumatoid arthritis'? | Whipple's disease: the great masquerader-a high level of suspicion is the key to diagnosis.
BACKGROUND
Whipple's disease is a chronic infectious disease that primarily affects the small intestine, but several organs can simultaneously be involved. The disease is caused by a gram-positive bacterium called Tropheryma whi... | Recovering | ReactionOutcome | CC BY | 33743602 | 19,977,136 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adhesion'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743624 | 19,082,899 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Balanoposthitis'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33743624 | 19,081,296 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bladder diverticulum'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743624 | 19,082,899 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Emphysematous pyelonephritis'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33743624 | 19,081,296 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Impaired driving ability'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743624 | 19,082,899 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lichen sclerosus'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743624 | 19,082,899 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrolithiasis'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33743624 | 19,081,296 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostatic abscess'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33743624 | 19,081,296 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostatitis'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33743624 | 19,081,296 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostatomegaly'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743624 | 19,082,899 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Residual urine volume increased'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743624 | 19,082,899 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urethral stenosis'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743624 | 19,082,899 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary retention'. | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743624 | 19,082,899 | 2021-03-20 |
What was the outcome of reaction 'Nephrolithiasis'? | Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports.
BACKGROUND
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significan... | Recovered | ReactionOutcome | CC BY | 33743624 | 19,081,296 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone density decreased'. | A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis.
Extragonadal endometriosis is a rare condition, and its disease manifestation and long-term prognosis have not been elucidated. We report an extragonadal endometriosis case c... | ESTROGENS, CONJUGATED, LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY | 33743689 | 19,101,551 | 2021-03-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hydronephrosis'. | A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis.
Extragonadal endometriosis is a rare condition, and its disease manifestation and long-term prognosis have not been elucidated. We report an extragonadal endometriosis case c... | ESTROGENS, CONJUGATED, LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY | 33743689 | 19,101,551 | 2021-03-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis.
Extragonadal endometriosis is a rare condition, and its disease manifestation and long-term prognosis have not been elucidated. We report an extragonadal endometriosis case c... | ESTROGENS, CONJUGATED, LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY | 33743689 | 19,101,551 | 2021-03-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyelonephritis acute'. | A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis.
Extragonadal endometriosis is a rare condition, and its disease manifestation and long-term prognosis have not been elucidated. We report an extragonadal endometriosis case c... | ESTROGENS, CONJUGATED, LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY | 33743689 | 19,101,551 | 2021-03-21 |
What was the outcome of reaction 'Bone density decreased'? | A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis.
Extragonadal endometriosis is a rare condition, and its disease manifestation and long-term prognosis have not been elucidated. We report an extragonadal endometriosis case c... | Not recovered | ReactionOutcome | CC BY | 33743689 | 19,101,551 | 2021-03-21 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.